Navigation Links
Calcium Channel Blocker Adalat GITS Offer Additional Benefits

ue to an anti-anginal and a vascular protective effect.


Efficient utilization of resources
Using the ACTION data, Poole-Wilson et al. showed that adding nifedipine GITS to the best practice therapy reduced the need for additional medication and also the use of expensive diagnostic and surgical procedures together with their associated costs. Basis for the calculation of hospital expenses was a reference hospital in the Netherlands. The estimated cost of medication was also based on drug pricing in the Netherlands. In total the incremental cost of the nifedipine GITS therapy was just about € 69 per year, or about € 3,036 per year of event free survival.


Bayer HealthCare
Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG, Germany. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide.

Bayer Schering Pharma
Bayer Schering Pharma AG, Germany, is a worldwide leading specialty pharmaceutical company. Its research and business activities are focused on the following areas: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims for leading positions in specialized markets worldwide. Using new ideas, Bayer Schering Pharma aims to make a contribution to medical progress and strives to improve the quality of life.

Forward-looking statements
This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known an
'"/>




Page: 1 2 3

Related medicine technology :

1. Calcium Plaque Build-up in the Arteries Leads to Coronary Heart Disease in Multi-Ethnic Groups
2. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
3. Analyzers Offer Point-of-Care Lipid Panels
4. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
5. Novel Human Tissue Transgenic Cancer Model May Offer Significant Advance Toward Accurately Modeling Human Cancer
6. MUSC Research Offers Hope for Those Resistant to Depression Treatment
7. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
10. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
11. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Calcium Channel Blocker Adalat GITS Offer Additional Benefits
(Date:7/30/2015)... MOUNTAIN VIEW, Calif. , July 30, 2015 /PRNewswire/ ... that it will release its second quarter 2015 financial ... 6, 2015.   In conjunction with the release, the ... community at 5:00 p.m. Eastern Time on ... results of the quarter and other business developments. ...
(Date:7/30/2015)... , July 30, 2015  EP Global Communications, ... have recently contacted the Company about discussing EPGL,s ... early as Monday, August 3, 2015.  Novartis CEO ... saying that the coming electronic contact lens market ... over the next several years.  Novartis partnered with ...
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... NATICK, Mass., May 4, 2011 Boston Scientific ... several milestones in the adoption of its SpyGlass® ... July 2007.  The SpyGlass System guides visualization and ... the pancreatico-biliary system, including the hepatic ducts.  It ...
... 4, 2011 Volcano Corporation (NASDAQ: VOLC ), ... therapy guidance tools designed to enhance the treatment of coronary ... first quarter of 2011 increased 22 percent versus revenues in ... ended March 31, 2011, Volcano reported revenues of $81.0 million, ...
Cached Medicine Technology:Boston Scientific's SpyGlass® Direct Visualization System Achieves Global Utilization Milestones 2Boston Scientific's SpyGlass® Direct Visualization System Achieves Global Utilization Milestones 3Boston Scientific's SpyGlass® Direct Visualization System Achieves Global Utilization Milestones 4Boston Scientific's SpyGlass® Direct Visualization System Achieves Global Utilization Milestones 5Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability 2Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability 3Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability 4Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability 5Volcano Achieves 22 Percent Increase in First Quarter Revenues; Sales Growth, Margin Expansion Drive Profitability 6
(Date:8/1/2015)... ... ... Phil Valentine – the Executive Director of Connecticut Community for Addiction Recovery (CCAR) – began ... and heading north. Since that day, Phil has hiked over 1400 miles in nine states. ... family. He visited CCAR and left an inspirational message to his staff: “You can ...
(Date:7/31/2015)... ... July 31, 2015 , ... When the weather turned hot and ... new type of sod called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) for ... commemorate introduction of this new type of sod, Super-Sod is giving away red Adirondack ...
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reliable source for authentic tickets for ... Park. The festival will end on Sunday, August 2nd. , Music ... Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment from ...
(Date:7/31/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... introduced its new store run by GoodThreads. The store can be accessed by ... and designs, many of which are customizable. The best part: whenever a product ...
(Date:7/31/2015)... ... ... There’s no better way to enjoy the summer weather than by being ... meal, making July the most appropriate to be National Hot Dog Month. King Kullen ... the next cookout different than the ones in the past. Celebrate National Hot Dog ...
Breaking Medicine News(10 mins):Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3
... and the University of Pittsburgh Medical Center will be ... conjunction with the G20 Pittsburgh Summit Sept. 24-25. These ... how and why the "eds and meds" sector of ... region,s success. The Eds-Meds program will begin at ...
... RUTHERFORD, N.J., Aug. 28 As concerns ... soar, and sales and profits are being diverted outside ... to keep their Vectra(R) products, and the health and ... Through their Bloodhound(R) Technology, a unique track-and-trace barcode system, ...
... , , , MUMBAI, ... Bloomberg: SUNP IN, NSE: SUN PHARMA, BSE: 524715) today announced ... with the U.S. Federal Trade Commission (FTC) and the Antitrust ... Hart-Scott-Rodino (HSR) Act waiting period in connection with the Tender ...
... ADD and more , FRIDAY, Aug. 28 (HealthDay News) -- ... appears that your "mind,s eye" acts like a spotlight to ... the right person. , Researchers from the Massachusetts Institute of ... for a specific tilted, colored bar among a field of ...
... , , Free ... Physician-Specific Information , , RICHMOND, Va., ... hospital discharges in Virginia. Virginia Health Information ... an updated, free, interactive online guide containing information on the ...
... , , , WASHINGTON, Aug. ... and firearm owners against greater government control of American society," says ... , "Seniors oppose Obama health care proposals at town ... period of economic difficulty because of concern about prospective Obama gun ...
Cached Medicine News:Health News:Summit VetPharm Helps Veterinarians Protect Against Product Diversion, Counterfeiting and Shrinkage Using Vectra(R) Bloodhound(R) Technology 2Health News:Summit VetPharm Helps Veterinarians Protect Against Product Diversion, Counterfeiting and Shrinkage Using Vectra(R) Bloodhound(R) Technology 3Health News:Sun Pharmaceutical Files HSR Application for Taro Tender Offer 2Health News:Sun Pharmaceutical Files HSR Application for Taro Tender Offer 3Health News:Brain May Use Its 'Mind's Eye' to Control Chaos 2Health News:VHI Releases Consumer Guide to Obstetrical Services in Virginia 2Health News:Firearm Owners and Seniors Coalesce Against Obama Agenda, Says Gun Law Expert 2
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum....
... Disc Arthroplasty System consists of a two-part ... which is inserted into the disc space ... balloon is then injected with the flowable ... implant that conforms to the shape and ...
... Automated EIA Analyzer is an exceptional ... of complex microplate-based assays. The system's ... to busy laboratories. For low volume ... processing of assays with common features ...
... CP* the performance of the ADVIA Centaur ... Available in a benchtop model with a footprint ... cm), the ADVIA Centaur CP fits in anywhere. ... your lab with optimal productivity, speed and efficiency ...
Medicine Products: